JP2002530419A - 平滑筋細胞増殖の阻害薬としてのベンジルグリコシルアミド - Google Patents

平滑筋細胞増殖の阻害薬としてのベンジルグリコシルアミド

Info

Publication number
JP2002530419A
JP2002530419A JP2000583922A JP2000583922A JP2002530419A JP 2002530419 A JP2002530419 A JP 2002530419A JP 2000583922 A JP2000583922 A JP 2000583922A JP 2000583922 A JP2000583922 A JP 2000583922A JP 2002530419 A JP2002530419 A JP 2002530419A
Authority
JP
Japan
Prior art keywords
maltosyl
acetyl
pharmaceutically acceptable
substituted
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000583922A
Other languages
English (en)
Japanese (ja)
Inventor
ロバート・エメット・マクデビット
フォレイク・オルウェミモ・アデバヨ
Original Assignee
アメリカン・ホーム・プロダクツ・コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アメリカン・ホーム・プロダクツ・コーポレイション filed Critical アメリカン・ホーム・プロダクツ・コーポレイション
Publication of JP2002530419A publication Critical patent/JP2002530419A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2000583922A 1998-11-24 1999-11-23 平滑筋細胞増殖の阻害薬としてのベンジルグリコシルアミド Pending JP2002530419A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19843398A 1998-11-24 1998-11-24
US09/198,433 1998-11-24
PCT/US1999/027823 WO2000031094A2 (fr) 1998-11-24 1999-11-23 Benzylglycosylamides utilises comme inhibiteurs de la proliferation cellulaire des muscles lisses

Publications (1)

Publication Number Publication Date
JP2002530419A true JP2002530419A (ja) 2002-09-17

Family

ID=22733363

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000583922A Pending JP2002530419A (ja) 1998-11-24 1999-11-23 平滑筋細胞増殖の阻害薬としてのベンジルグリコシルアミド

Country Status (7)

Country Link
EP (1) EP1144426A2 (fr)
JP (1) JP2002530419A (fr)
CN (1) CN1333780A (fr)
AU (1) AU1829300A (fr)
BR (1) BR9915606A (fr)
CA (1) CA2350755A1 (fr)
WO (1) WO2000031094A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339064B1 (en) 1998-11-24 2002-01-15 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6362170B1 (en) 1998-11-24 2002-03-26 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
WO2000031093A2 (fr) * 1998-11-24 2000-06-02 American Home Products Corporation Benzylglycosylamides utilises comme inhibiteurs de proliferation des cellules du muscle lisse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3655327B2 (ja) * 1994-05-09 2005-06-02 三井化学株式会社 オリゴ糖鎖を有するスチレン誘導体およびその製造方法
DE4436164A1 (de) * 1994-10-10 1996-04-11 Hoechst Ag Neue Kohlenhydratkonjugate als Inhibitoren der Zelladhäsion
WO2000031093A2 (fr) * 1998-11-24 2000-06-02 American Home Products Corporation Benzylglycosylamides utilises comme inhibiteurs de proliferation des cellules du muscle lisse

Also Published As

Publication number Publication date
BR9915606A (pt) 2001-08-14
CN1333780A (zh) 2002-01-30
WO2000031094A3 (fr) 2000-12-21
WO2000031094A2 (fr) 2000-06-02
AU1829300A (en) 2000-06-13
EP1144426A2 (fr) 2001-10-17
CA2350755A1 (fr) 2000-06-02

Similar Documents

Publication Publication Date Title
JP2002530419A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルグリコシルアミド
US6339064B1 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
JP2002531579A (ja) 平滑筋細胞増殖の阻害薬としてのアセチルベンジルマルトシド
US6340670B1 (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
JP2002530424A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルマルトシド
US6187755B1 (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
JP2002530421A (ja) 平滑筋細胞増殖の阻害剤としてのアセタールベンジルマルトシド
MXPA01005179A (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
JP2002530418A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルグリコシルアミド
US6451767B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US6291434B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
MXPA01005178A (en) Benzylmaltosides as inhibitors of smooth muscle cell proliferation
JP2002530420A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルマルトトリオシド
JP2003521460A (ja) 平滑筋細胞増殖の阻害薬としてのアセチル化ベンジルマルトシド
US6362170B1 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6258784B1 (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
JP2002530417A (ja) 平滑筋細胞増殖の阻害薬としてのベンジルラクトビオナミド
MXPA01005174A (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
MXPA01005172A (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
MXPA01005176A (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
MXPA01005173A (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
US20050176652A1 (en) Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
MXPA01005171A (es) Bencilglicosilamidas como inhibidores de la proliferacion de celulas de musculoliso